4,123 Shares in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Purchased by Scotia Capital Inc.

Scotia Capital Inc. acquired a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 4,123 shares of the company’s stock, valued at approximately $271,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of the company. Raymond James Financial Inc. bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the 4th quarter valued at approximately $4,472,000. Advisory Services Network LLC boosted its holdings in iShares U.S. Pharmaceuticals ETF by 7.1% in the fourth quarter. Advisory Services Network LLC now owns 4,439 shares of the company’s stock worth $292,000 after purchasing an additional 293 shares during the period. Bank of Montreal Can increased its stake in iShares U.S. Pharmaceuticals ETF by 134.4% during the fourth quarter. Bank of Montreal Can now owns 12,926 shares of the company’s stock valued at $849,000 after purchasing an additional 7,412 shares during the last quarter. Orion Portfolio Solutions LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 3.2% during the fourth quarter. Orion Portfolio Solutions LLC now owns 10,465 shares of the company’s stock worth $688,000 after purchasing an additional 321 shares during the period. Finally, JPMorgan Chase & Co. lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 2,176.8% in the 4th quarter. JPMorgan Chase & Co. now owns 188,567 shares of the company’s stock worth $12,393,000 after buying an additional 180,285 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Stock Performance

NYSEARCA IHE opened at $62.95 on Wednesday. iShares U.S. Pharmaceuticals ETF has a one year low of $58.97 and a one year high of $73.28. The company has a 50-day simple moving average of $68.88 and a 200-day simple moving average of $68.58. The firm has a market capitalization of $572.85 million, a PE ratio of 21.53 and a beta of 0.63.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.